Treatment with 40 mg/kg CPUY201112 remarkably induced the expression of Hsp70 and decreased the expression of Akt, suggesting that tumor regression was caused by CPUY201112 through targeting Hsp90. The gene discussed is HSP90AA1; the disease is neoplasm.